Reports indicate that Eliquis is on its way to yielding the same amount of dangers as other blood thinning drugs, such as Pradaxa and Xarelto. In June of 2015, a lawsuit was filed claiming that a patient was given Eliquis without being warned about either the lack of an antidote or its potential side effects. After suffering from gastrointestinal bleeding, the patient died. While it is considered one of the newer generation anticoagulants, Eliquis is one of three that have been linked to an increased risk of uncontrolled bleeding. Eliquis was introduced in 2012 with advertising targeted directly at consumers, claiming that its advantage lies in the lack of blood monitoring required. Not bad to be perceived as the preferred choice over Pradaxa and Xarelto, but the proof simply isn’t there.
Eliquis – Not a One-Dose-Fits-All Drug
The stated dose for Eliquis is five milligrams, taken orally, twice daily. The only variable that should sway that would be a patient’s weight. But, that isn’t accurate. For example, one fact that isn’t made clear is that patients with kidney disease need a lower dose; this is a fairly significant point to omit. Since a patient must have his or her level of blood thinning tested in order to know if their dosage is under- or over-prescribed, it was apparently getting too complicated for the manufacturer to address. In other words, the stated dosage should not be considered safe until further tests are conducted on a per-patient basis.
An Increasingly Questionable Clinical Trial
How safe is Eliquis? Some studies have compared the safety and effectiveness of Eliquis to Warfarin, an anticoagulant that was FDA-approved almost 60 years ago. The ARISTOTLE trial, completed in 2011, compared more than 18,000 patients with nonvalvular atrial fibrillation. Early results from ARISTOTLE are reported to position Eliquis as the superior treatment; however, Eliquis’ future still depends largely on the market’s reaction to that information. A reality that cannot be ignored is that both the FDA and the ARISTOTLE trial pointed to the fact that the most common reason for discontinuing treatment was for bleeding-related adverse reactions.
Anticoagulants Have Billions at Stake
Despite the 58,000 people who, since 2010, have reported a serious side effect from using an anticoagulant (e.g., a major bleeding episode), and the 8,000 deaths that have been linked to the drugs, sales of Pradaxa, Xarelto, and Eliquis have skyrocketed. According to data from IMS Health, a market research firm, more than 10 million prescriptions were dispensed for these drugs in 2014. What helped bolster those sales? Many say it’s a function of the false claims made and the lack of warnings. Others say it’s because of the new system introduced that determines stroke risk, a system adopted as part of treatment guidelines by leading medical societies in the United States and Europe. But, alas, these institutions were also found to have received millions of dollars from drug manufacturers, or have personal ties to them in one way or another.
What Are the Most Common Side Effects of Eliquis?
The most common side effects of Eliquis are related to bleeding in the gastrointestinal tract, soft tissues, and urinary tract. The risk of bleeding is increased if Eliquis is taken in conjunction with other medicines that are known to increase the risk of bleeding, such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin (Coumadin), heparin, selective serotonin reuptake inhibitors (SSRIs), or serotonin norepinephrine reuptake inhibitors (SNRIs), among others.
Get Immediate and Effective Legal Help from Attorneys Who Have Expertise and Knowledge Regarding the Dangers Associated with Eliquis
If you or a loved one has experienced serious side effects after taking Eliquis, it is critical to understand your legal rights in order to recover any and all damages suffered. We are dedicated to evaluating carefully the facts of your particular situation and effectively pursuing appropriate legal action to fully compensate you for your losses. Take charge of your health and financial well-being and contact Slack & Davis today for a free, no-obligation consultation with one of our highly experienced medical and pharmaceutical attorneys.